Cargando…

Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era

BACKGROUND: This study evaluated relapse patterns and survival in advanced Hodgkin lymphoma (HL) patients treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) with positron emission tomography (PET) used for staging and response assessment. PATIENTS AND METHODS: Patients aged 18 y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lapuz, Carminia, Enjeti, Anoop K, O’Brien, Peter C, Capp, Anne L, Holliday, Elizabeth G, Gupta, Sanjiv A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467364/ https://www.ncbi.nlm.nih.gov/pubmed/31360090 http://dx.doi.org/10.2147/BLCTT.S160404

Ejemplares similares

Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era
por: Jennane, Selim, et al.
Publicado: (2022)

Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography
por: Kasamon, Yvette L.
Publicado: (2011)

Malaria masquerading as relapse of Hodgkin's lymphoma on contrast enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: A diagnostic dilemma
por: Jeph, Sunil, et al.
Publicado: (2014)

The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma
por: Eslick, R, et al.
Publicado: (2017)

The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma
por: Seth, Rachna, et al.
Publicado: (2012)

Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin’s lymphoma
por: Kim, Yu Ri, et al.
Publicado: (2021)

18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma
por: Shelly, M. J., et al.
Publicado: (2012)

Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma
por: Huntington, Scott F, et al.
Publicado: (2019)

Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma
por: Kung, Boom Ting, et al.
Publicado: (2015)

Paraneoplastic syndrome turned out to be non-Hodgkin's lymphoma on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography
por: Sahoo, Manas Kumar, et al.
Publicado: (2016)

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Hodgkin's Lymphoma: Diagnostic Challenge during COVID Vaccination
por: Usmani, Sharjeel, et al.
Publicado: (2021)

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Hodgkin's Lymphoma, COVID Vaccination, and Appropriate Investigation Time
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group
por: Cerci, Juliano Júlio, et al.
Publicado: (2018)

Positron emission tomography in the COVID-19 pandemic era
por: Jin, Chentao, et al.
Publicado: (2021)

Neurolymphomatosis – Rare presentation in non-Hodgkin’s lymphoma: The role of (18)F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging
por: Fatima, Nosheen, et al.
Publicado: (2020)

Relationship between semiquantitative (18)F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma
por: Kahle, X. U., et al.
Publicado: (2019)

Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin’s or Non-Hodgkin’s Lymphoma?
por: Çetin, Güven, et al.
Publicado: (2015)

Utility of F-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Patient Presenting with Acute Paraparesis in Detecting Isolated Relapse of Non-Hodgkin's Lymphoma Infiltrating the Spinal Cord
por: Jain, Tarun Kumar, et al.
Publicado: (2019)

The Correlation Between Pre-treatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters and Clinical Prognostic Factors in Pediatric Hodgkin Lymphoma
por: Tatcı, Ebru, et al.
Publicado: (2017)

Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
por: Randall, Michael P., et al.
Publicado: (2023)

18 Fluoride-fluorodeoxyglucose positron emission tomography in initial staging and response assessment of primary non-Hodgkin lymphoma of the tibia
por: Harisankar, Chidambaram Natrajan Balasubramanian, et al.
Publicado: (2014)

The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin's Lymphoma: A Meta-Analysis
por: Zhu, Yuyuan, et al.
Publicado: (2013)

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2021)

Isolated Splenic Tuberculosis Masquerading as Disease Progression of Hodgkin's Lymphoma on Interim(18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan
por: Dey, Sudip, et al.
Publicado: (2021)

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
por: Hain, S F, et al.
Publicado: (2000)

Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID‐19 vaccination: A mimicker of disease progression in Hodgkin lymphoma
por: Suleman, Adam, et al.
Publicado: (2021)

Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.
por: Rubio, C., et al.
Publicado: (1997)

The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
por: Beard, S M, et al.
Publicado: (2000)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

Accuracy of Positron Emission Tomography-Computed Tomography in Bone Marrow Involvement Lymphoma
por: Çekdemir, Demet, et al.
Publicado: (2015)

Nodular fasciitis mimicking recurrent lymphoma on positron emission tomography–computed tomography
por: Zhou, Qiao, et al.
Publicado: (2016)

Positron emission tomography-computed tomography in subcutaneous panniculitis-like T-cell lymphoma
por: Bikkina, Prathyusha, et al.
Publicado: (2019)

Utero-Ovarian Involvement in Non-Hodgkin's Lymphoma on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Case Series and Literature Review
por: Saini, Vivek Kumar, et al.
Publicado: (2022)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography–Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study
por: Parsons, Susan K., et al.
Publicado: (2023)

Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Tateishi, Ukihide, et al.
Publicado: (2015)

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients
por: Zinzani, P L, et al.
Publicado: (2004)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
por: Kurch, Lars, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcqostbsg0as40cnsdotia0d1c